Publicité
Publicité
UPB
Upstream Bio, Inc. Common Stock
29.77
USDSponsorisé
+2.23
+8.08%
09 janv., 15:59 UTC -5
Fermé
Après-marché
29.75
-0.01
-0.05%
UPB Rapports sur les bénéfices
Ratio de surprise positive
UPB a dépassé 1 des 5 dernières estimations.
20%
Prochain rapport
Date du prochain rapport
10 mars 2026
Estimate for Q4 25 (Revenue/ EPS)
$614.41K
/-$0.68
Variation implicite de Q3 25 (Revenue/ EPS)
-10.04%
/+7.94%
Variation implicite de Q4 24 (Revenue/ EPS)
+0.23%
/-57.23%
Upstream Bio, Inc. Common Stock earnings per share and revenue
On 05 nov. 2025, UPB reported earnings of -0.63 USD per share (EPS) for Q3 25, beating the estimate of -0.78 USD, resulting in a 20.23% surprise. Revenue reached 683.00 mille, compared to an expected 651.45 mille, with a 4.84% difference. The market reacted with a -4.27% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 9 analystes forecast an EPS of -0.68 USD, with revenue projected to reach 614.41 mille USD, implying an hausse of 7.94% EPS, and baisse of -10.04% in Revenue from the last quarter.
FAQ
What were Upstream Bio, Inc. Common Stock's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Upstream Bio, Inc. Common Stock reported EPS of -$0.63, beating estimates by 20.23%, and revenue of $683.00K, 4.84% above expectations.
How did the market react to Upstream Bio, Inc. Common Stock's Q3 2025 earnings?
The stock price moved down -4.27%, changed from $25.04 before the earnings release to $23.97 the day after.
When is Upstream Bio, Inc. Common Stock expected to report next?
The next earning report is scheduled for 10 mars 2026.
What are the forecasts for Upstream Bio, Inc. Common Stock's next earnings report?
Based on 9
analystes, Upstream Bio, Inc. Common Stock is expected to report EPS of -$0.68 and revenue of $614.41K for Q4 2025.
Which companies are reporting earnings today?
Chèque FXEmpire's Earnings Calendar for today's list of reporting companies.
Publicité